Cargando…
Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis
INTRODUCTION: In 1995, the use of autologous hematopoietic stem-cell transplantation (AHSCT), which was previously used to treat hematological tumors, was introduced for severe autoimmune diseases such as multiple sclerosis (MS). AHSCT has proven its safety over the past few years due to technical a...
Autores principales: | Nabizadeh, Fardin, Pirahesh, Kasra, Rafiei, Nazanin, Afrashteh, Fatemeh, Ahmadabad, Mona Asghari, Zabeti, Aram, Mirmosayyeb, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333355/ https://www.ncbi.nlm.nih.gov/pubmed/35902484 http://dx.doi.org/10.1007/s40120-022-00389-x |
Ejemplares similares
-
Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis
por: Nabizadeh, Fardin, et al.
Publicado: (2023) -
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
por: Nabizadeh, Fardin, et al.
Publicado: (2022) -
Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022) -
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015) -
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)